KR102089721B1 - 비타민 c 및 아연 정제의 안정 조성물 - Google Patents

비타민 c 및 아연 정제의 안정 조성물 Download PDF

Info

Publication number
KR102089721B1
KR102089721B1 KR1020187011070A KR20187011070A KR102089721B1 KR 102089721 B1 KR102089721 B1 KR 102089721B1 KR 1020187011070 A KR1020187011070 A KR 1020187011070A KR 20187011070 A KR20187011070 A KR 20187011070A KR 102089721 B1 KR102089721 B1 KR 102089721B1
Authority
KR
South Korea
Prior art keywords
vitamin
stable
zinc
swallow
oral tablet
Prior art date
Application number
KR1020187011070A
Other languages
English (en)
Korean (ko)
Other versions
KR20180064420A (ko
Inventor
웬델 지. 멘도자
리타 조세피나 엠. 산토스
케니 유. 데
Original Assignee
노벡스 사이언스 피티이 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 노벡스 사이언스 피티이 리미티드 filed Critical 노벡스 사이언스 피티이 리미티드
Publication of KR20180064420A publication Critical patent/KR20180064420A/ko
Application granted granted Critical
Publication of KR102089721B1 publication Critical patent/KR102089721B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020187011070A 2015-10-16 2015-10-16 비타민 c 및 아연 정제의 안정 조성물 KR102089721B1 (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/PH2015/000016 WO2017065623A1 (en) 2015-10-16 2015-10-16 Stable composition of vitamin c and zinc tablet

Publications (2)

Publication Number Publication Date
KR20180064420A KR20180064420A (ko) 2018-06-14
KR102089721B1 true KR102089721B1 (ko) 2020-03-16

Family

ID=58517594

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020187011070A KR102089721B1 (ko) 2015-10-16 2015-10-16 비타민 c 및 아연 정제의 안정 조성물

Country Status (8)

Country Link
KR (1) KR102089721B1 (pt)
CN (1) CN108347990A (pt)
BR (1) BR112018007634A2 (pt)
HK (1) HK1257130A1 (pt)
MY (1) MY191729A (pt)
PH (1) PH12018500791A1 (pt)
TW (1) TW201716063A (pt)
WO (1) WO2017065623A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114469883A (zh) * 2020-10-27 2022-05-13 河北科星药业有限公司 一种治疗仔猪坏血症的氨酪酸维生素c片、制备方法和应用
WO2023031946A1 (en) * 2021-09-01 2023-03-09 Kusum Healthcare Pvt. Ltd. Effervescent pharmaceutical composition of ascorbic acid and zinc
CN114306269A (zh) * 2021-12-27 2022-04-12 西华大学 一种柠檬多肽泡腾片的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017123103A1 (en) 2016-01-15 2017-07-20 Dee, Kennie U. Stable and palatable composition of vitamin c and zinc lozenge tablets

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020039597A1 (en) * 1998-04-20 2002-04-04 Koji Ukai Stabilized compositions containing benzimidazole-type compounds
CN1266652A (zh) * 1999-03-12 2000-09-20 江苏康禾食品总厂 氨基酸泡腾剂
GB0330009D0 (en) * 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations
CA2560595C (en) * 2004-03-29 2013-01-22 Wyeth Multi-vitamin and mineral nutritional supplements
CN1327838C (zh) * 2004-07-08 2007-07-25 北京科信必成医药科技发展有限公司 维生素c口腔崩解片及其制备方法
US8491937B2 (en) * 2007-02-15 2013-07-23 Wyeth Llc Stability in vitamin and mineral supplements
CA2750216A1 (en) * 2008-12-15 2010-07-08 Fleming And Company, Pharmaceuticals Rapidly dissolving vitamin formulation and methods of using the same
US20130052278A1 (en) * 2010-03-11 2013-02-28 Rich Vitamins Llc Quick dissolve nutritional powder
CN102406623B (zh) * 2010-09-26 2014-08-27 上海星泰医药科技有限公司 一种尼索地平控释片剂及其制备方法
WO2012085043A2 (en) * 2010-12-22 2012-06-28 Basf Se Rapidly disintegrating, solid coated dosage form
WO2013159861A1 (de) * 2012-04-27 2013-10-31 Merck Patent Gmbh Tabletten mit überzug und deren herstellung
CN104382934A (zh) * 2013-08-19 2015-03-04 宣城柏维力生物工程有限公司 一种孕妇多维片
CN103751327B (zh) * 2014-01-15 2016-08-24 刘保国 葡萄糖酸锌vc泡腾片
CN104432060B (zh) * 2014-12-18 2016-10-05 郑州拓洋实业有限公司 一种高锌低钠维生素c泡腾片及其制备方法
CN104784206B (zh) * 2015-03-16 2017-07-14 浙江圣博康药业有限公司 一种多维元素分散片

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017123103A1 (en) 2016-01-15 2017-07-20 Dee, Kennie U. Stable and palatable composition of vitamin c and zinc lozenge tablets

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
International Journal of Pharmaceutics, Vol. 33, pp.115-124 (1986.).*
미국 특허출원공개공보 US2010/0190739호(2010.07.29.).*

Also Published As

Publication number Publication date
BR112018007634A2 (pt) 2018-11-06
KR20180064420A (ko) 2018-06-14
PH12018500791B1 (en) 2018-10-29
PH12018500791A1 (en) 2018-10-29
HK1257130A1 (zh) 2019-10-11
TW201716063A (zh) 2017-05-16
WO2017065623A1 (en) 2017-04-20
CN108347990A (zh) 2018-07-31
MY191729A (en) 2022-07-13

Similar Documents

Publication Publication Date Title
AU2005271194B2 (en) Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
EP2468361B1 (en) Vildagliptin Formulations
EP0749308B1 (en) Film coated tablet of paracetamol and domperidone
KR102089721B1 (ko) 비타민 c 및 아연 정제의 안정 조성물
CA2915432A1 (en) Disintegrant free composition of cinacalcet
JP2017523149A (ja) エドキサバンの医薬組成物
JP2012512242A (ja) ウデナフィル含有徐放性製剤を製造するための制御放出組成物
WO2009049648A2 (en) Improved pharmaceutical composition containing antiviral agent and method for the preparation thereof
KR20190037182A (ko) 에스오메프라졸 및 그의 약학적으로 허용가능한 염을 함유하는 다중 투여 단위 정제를 포함한 약제학적 조성물 및 그의 제조 방법
KR101811700B1 (ko) 레보드로프로피진 함유 서방정 및 이의 제조방법
KR102497608B1 (ko) 모사프리드 및 프로톤펌프억제제를 함유하는 복합제제
EP1803457A1 (en) Pharmaceutical composition containing montelukast
CA3069948C (en) A solid oral fixed dose composition comprising metformin, valsartan and atorvastatin
EP3511001B1 (en) Pirfenidone-containing tablet and capsule formulation
KR102579095B1 (ko) 에스오메프라졸 또는 이의 약학적으로 허용 가능한 염을 포함하는 약제학적 제형
JP2021518424A (ja) 様々な用量のレナリドミドの経口用錠剤組成物
EP2676661B1 (en) Orally administered sustained-release triple-layer pill containing tamsulosin or pharmaceutically acceptable salt thereof
JPWO2014034929A1 (ja) ヒドロモルフォン塩酸塩含有の経口用徐放性医薬組成物
CN114129532B (zh) 一种枸橼酸铋钾制剂
EP4302832A1 (en) Palbociclib formulation containing glucono delta lactone
KR102231289B1 (ko) 고함량 콘드로이틴설페이트 약학 제제 및 이의 제조방법
EP4166132A1 (en) Pharmaceutical composite formulation comprising proton pump inhibitor and antacid, and method for preparing same
KR102246066B1 (ko) 레보드로프로피진 함유 서방정의 제조방법
JP6676816B1 (ja) Ｌ−システイン配合ビタミンｃ高含有圧縮成形製剤
KR20180101530A (ko) 안정하고 맛있는 비타민 c와 아연 로젠지 정제 조성물

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant